Literature DB >> 8471571

Recovery from intravenous sedation with midazolam--the value of flumazenil.

P J Thomson1, P Coulthard, A T Snowdon, K Mitchell.   

Abstract

A total of 40 patients receiving intravenous midazolam for surgical removal of impacted wisdom teeth were randomly assigned to recover either spontaneously or undergo reversal by the benzodiazepine antagonist flumazenil. Whilst initial postoperative recovery to a 'fully awake' state occurred more rapidly in the reversal group, objective psychomotor testing revealed significantly poorer performance postoperatively compared with spontaneously recovering patients; this emphasises the need to retain patients for at least 1 h prior to discharge home.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8471571     DOI: 10.1016/0266-4356(93)90170-2

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  4 in total

1.  Summary of the scientific literature for pain and anxiety control in dentistry.

Authors:  L C Hassett
Journal:  Anesth Prog       Date:  1994

Review 2.  Flumazenil in dentistry.

Authors:  C Rodrigo
Journal:  Anesth Prog       Date:  1995

Review 3.  Reversal Agents in Sedation and Anesthesia Practice for Dentistry.

Authors:  Michelle Wong
Journal:  Anesth Prog       Date:  2022-04-01

4.  Clinical recovery time from conscious sedation for dental outpatients.

Authors:  Tohru Takarada; Michio Kawahara; Masahiro Irifune; Chie Endo; Yoshitaka Shimizu; Kiyoshi Maeoka; Chikako Tanaka; Sotaro Katayama
Journal:  Anesth Prog       Date:  2002
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.